UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways

Cancer treatment reviews, 2012-10, Vol.38 (6), p.698-707

2012

Volltextzugriff (PDF)

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer

Science translational medicine, 2015-04, Vol.7 (283), p.283ra51

2015

Volltextzugriff (PDF)

The Strategy of PIKing a Target: What Is AKTually Most Effective?

Clinical cancer research, 2018-05, Vol.24 (9), p.2029-2031

2018

Volltextzugriff (PDF)

The effect of altitude and grazing on seedling establishment of woody species in central Argentina

Forest ecology and management, 2013-03, Vol.291, p.300-307

2013

Volltextzugriff (PDF)

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research

Cancer treatment reviews, 2010-05, Vol.36 (3), p.206-215

2010

Volltextzugriff (PDF)

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Scientific reports, 2024-03, Vol.14 (1), p.6675-6675, Article 6675

2024

Volltextzugriff (PDF)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

Nature communications, 2020-07, Vol.11 (1), p.3747-3747, Article 3747

2020

Volltextzugriff (PDF)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-08, Vol.12 (1), p.5112-5112, Article 5112

2021

Volltextzugriff (PDF)

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

Breast cancer research : BCR, 2023-10, Vol.25 (1), p.1-123, Article 123

2023

Volltextzugriff (PDF)

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Cell reports (Cambridge), 2019-06, Vol.27 (12), p.3573-3586.e7

2019

Volltextzugriff (PDF)

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

PloS one, 2024-07, Vol.19 (7), p.e0305222

2024

Volltextzugriff (PDF)

Molecular analyses of triple-negative breast cancer in the young and elderly

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.20-20, Article 20

2021

Volltextzugriff (PDF)

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer

Oncotarget, 2016-09, Vol.7 (37), p.59640-59651

2016

Volltextzugriff (PDF)

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.26-18, Article 26

2021

Volltextzugriff (PDF)

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Breast cancer research and treatment, 2009-04, Vol.114 (3), p.479-484

2009

Volltextzugriff (PDF)

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

Science signaling, 2014-03, Vol.7 (318), p.ra29

2014

Volltextzugriff (PDF)

An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

Clinical cancer research, 2021-10, Vol.27 (20), p.5557-5565

2021

Volltextzugriff (PDF)

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

Molecular cell, 2021-04, Vol.81 (7), p.1453-1468.e12

2021

Volltextzugriff (PDF)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Nature communications, 2021-09, Vol.12 (1), p.5588-5588, Article 5588

2021

Volltextzugriff (PDF)

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly

Breast cancer research : BCR, 2021-02, Vol.23 (1), p.28-28, Article 28

2021

Volltextzugriff (PDF)

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

Translational oncology, 2022-08, Vol.22, p.101464-101464, Article 101464

2022

Volltextzugriff (PDF)

Deletion of the PER3 Gene on Chromosome 1p36 in Recurrent ER-Positive Breast Cancer

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3770-3778

2010

Volltextzugriff (PDF)

Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer

JOURNAL OF CLINICAL ONCOLOGY, 2019, Vol.37 (15_suppl), p.583-583

2019

Volltextzugriff (PDF)

Algunas consideraciones sobre la enseñanza de la Farmacología en la carrera de Estomatología en Cuba

Edumecentro, 2021-12, Vol.13 (4), p.288-302

Bosch Nuñez, Ana Ibis

2021

Volltextzugriff (PDF)

1 – 25 von 978

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(869)
Mit Volltextzugriff
(871)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(535)
Life Sciences & Biomedicine
(457)
Humans
(316)
Female
(214)
Male
(173)
Middle Aged
(137)
Adult
(123)
Aged
(120)
Oncology
(115)
Biological And Medical Sciences
(79)
Animals
(72)
Medical Sciences
(68)
Patients
(55)
Spain
(55)
Aged, 80 And Over
(52)
Prognosis
(51)
Retrospective Studies
(49)
Risk Factors
(46)
Science & Technology - Other Topics
(44)
Infectious Diseases
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer

The Strategy of PIKing a Target: What Is AKTually Most Effective?

The effect of altitude and grazing on seedling establishment of woody species in central Argentina

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research

Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcome

Molecular analyses of triple-negative breast cancer in the young and elderly

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer

Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

Strategies to design clinical studies to identify predictive biomarkers in cancer research

Deletion of the PER3 Gene on Chromosome 1p36 in Recurrent ER-Positive Breast Cancer

Health-related quality of life in the Swedish PREDIX HER2 trial, evaluating docetaxel, trastuzumab, pertuzumab versus trastuzumab emtansine as neoadjuvant treatment of HER2-positive breast cancer

Algunas consideraciones sobre la enseñanza de la Farmacología en la carrera de Estomatología en Cuba

Suchergebnisse filtern